Anzeige
Mehr »
Montag, 30.06.2025 - Börsentäglich über 12.000 News
Diese KI-Biotech-Aktie revolutioniert die Krebstherapie: Lernen Sie Rakovina Therapeutics kennen
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
380 Leser
Artikel bewerten:
(1)

Irish Higher Education Institutions and Elsevier Sign a Pilot Transformative Agreement to Support Open Access for Research in Ireland

DUBLIN, Feb. 18, 2020 /PRNewswire/ -- A consortium of publicly-funded Irish higher education institutions and Elsevier, a global leader in information analytics specializing in science and health, have agreed to the country's first open access program with a major scientific publisher towards the goal of full open access to Irish research publications.

Elsevier Logo

The three-year agreement means Irish researchers from 19 institutions will have access to the entire Freedom Collection of 16 million publications from 2,500 journals published by Elsevier and its society partners on ScienceDirect, Elsevier's leading platform of peer-reviewed scholarly literature. The agreement also facilitates a transition to open access and enables Irish researchers to publish more than 70 percent of their research without having to pay an Article Publishing Charge (APC).

Cathal McCauley, Co-Chair of the Irish Consortium, said: "Our agreement with Elsevier is a significant step towards our ultimate goal of achieving 100 percent open access for Irish research, in the shortest possible time. It will enable the latest research to be available to all, at the point of publication. We look forward to working closely with Elsevier to use the data gathered from this trial, to improve their OA offering in future agreements."

Elsevier is one of the world's leading subscription and open access publishers, enabling researchers to stay up-to-date with the latest findings in science, technology and health from around the world.

Gino Ussi, Executive Vice President, Elsevier, said: "We're delighted to have concluded this new national agreement in Ireland and we look forward to continuing to support the Irish research community in advancing its ambitious goals. Elsevier is committed to empowering knowledge and remains one of the fastest growing open access publishers in the world, with a 40 percent increase in articles published in this way in 2019 than the previous year."

About the Consortium of Irish higher education institutions

The Consortium consists of seven universities, eleven institutes of technology and Technological University Dublin. The Consortium's work has been in collaboration with IReL (the Irish Research e-Library Consortium), IUA (the Irish Universities Association) and THEA (the Technological Higher Education Association).

The consortium members are:

  • Athlone Institute of Technology
  • Cork Institute of Technology
  • Dublin City University
  • Dún Laoghaire Institute of Art, Design + Technology
  • Dundalk Institute of Technology
  • Galway-Mayo Institute of Technology
  • Institute of Technology, Carlow
  • Institute of Technology, Sligo
  • Institute of Technology, Tralee
  • Letterkenny Institute of Technology
  • Limerick Institute of Technology
  • Maynooth University
  • National University of Ireland, Galway
  • Technological University Dublin
  • Trinity College Dublin
  • University College Cork
  • University College Dublin
  • University of Limerick
  • Waterford Institute of Technology

About Elsevier

Elsevier is a global information analytics business that helps scientists and clinicians to find new answers, reshape human knowledge, and tackle the most urgent human crises. For 140 years, we have partnered with the research world to curate and verify scientific knowledge. Today, we're committed to bringing that rigor to a new generation of platforms. Elsevier provides digital solutions and tools in the areas of strategic research management, R&D performance, clinical decision support, and professional education; including ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath. Elsevier publishes over 2,500 digitized journals, including The Lancet and Cell, 39,000 e-book titles and many iconic reference works, including Gray's Anatomy. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com

Logo - https://mma.prnewswire.com/media/754760/Elsevier_Logo.jpg

Media contacts
Cathal McCauley, University Librarian, Co-Chair of the Irish Consortium
Maynooth University
+353-1-708-38-81
cathal.mccauley@mu.ie

Andrew Davis, Global Communications
Elsevier
+44-7393-242-466
andrew.davis@elsevier.com

© 2020 PR Newswire
Zeitenwende! 3 Uranaktien vor der Neubewertung
Ende Mai leitete US-Präsident Donald Trump mit der Unterzeichnung mehrerer Dekrete eine weitreichende Wende in der amerikanischen Energiepolitik ein. Im Fokus: der beschleunigte Ausbau der Kernenergie.

Mit einem umfassenden Maßnahmenpaket sollen Genehmigungsprozesse reformiert, kleinere Reaktoren gefördert und der Anteil von Atomstrom in den USA massiv gesteigert werden. Auslöser ist der explodierende Energiebedarf durch KI-Rechenzentren, der eine stabile, CO₂-arme Grundlastversorgung zwingend notwendig macht.

In unserem kostenlosen Spezialreport erfahren Sie, welche 3 Unternehmen jetzt im Zentrum dieser energiepolitischen Neuausrichtung stehen, und wer vom kommenden Boom der Nuklearindustrie besonders profitieren könnte.

Holen Sie sich den neuesten Report! Verpassen Sie nicht, welche Aktien besonders von der Energiewende in den USA profitieren dürften, und laden Sie sich das Gratis-PDF jetzt kostenlos herunter.

Dieses exklusive Angebot gilt aber nur für kurze Zeit! Daher jetzt downloaden!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.